ProfileGDS4132 / 243477_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 27% 22% 35% 29% 30% 26% 22% 25% 25% 32% 24% 27% 24% 35% 28% 25% 28% 26% 31% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10165.511527
GSM201543Muscle PCOS pioglitazone 12143.585622
GSM201544Muscle PCOS pioglitazone 16190.473935
GSM201545Muscle PCOS pioglitazone 20177.385229
GSM201829Muscle PCOS pioglitazone 23178.78830
GSM201830Muscle PCOS pioglitazon 25162.662126
GSM201831Muscle PCOS pioglitazone 27145.2622
GSM201832Muscle PCOS pioglitazone 3161.528125
GSM201833Muscle PCOS pioglitazone 4156.785425
GSM201834Muscle PCOS pioglitazone 8177.999332
GSM201835Muscle PCOS after pioglitazone 10244.664724
GSM201836Muscle PCOS after pioglitazone 12254.948727
GSM201837Muscle PCOS after pioglitazone 16243.650324
GSM201838Muscle PCOS after pioglitazone 20277.927135
GSM201839Muscle PCOS after pioglitazone 23261.871628
GSM201840Muscle PCOS after pioglitazone 25256.20325
GSM201841Muscle PCOS after pioglitazone 27253.853528
GSM201842Muscle PCOS after pioglitazone 3249.188126
GSM201843Muscle PCOS after pioglitazone 4275.021331
GSM201844Muscle PCOS after pioglitazone 8248.648523